Email: cspc@cspc.cn

Contact Us
EN

News

News

Home > Media > News > SYH2046 TABLETS OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S.

SYH2046 TABLETS OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S.

May 09, 2025

a250509a_00.png

Previous: VONOPRAZAN FUMARATE TABLETS OBTAINS DRUG REGISTRATION APPROVAL

Next: JMT202 (RECOMBINANT FULLY HUMAN ANTI-βKLOTHO MONOCLONAL ANTIBODY DRUG) OBTAINS CLINICAL TRIAL APPROVAL IN THE U.S.

Contact Us

Phone:

+86 311 8703 7015

Email:

cspc@cspc.cn

Products

Science

About Us

Legal terms Privacy protection
Copyright © CSPC Pharmaceutical Group Co., Ltd. All Rights Reserved |

Wechat